A Director of Clinical Effectiveness and a Director of Strategy and Transformation will join the Board, which has already been strengthened this year with the addition of new Non-Executive Directors Tony Allen and Tony Bristlin and Associate Non-Executive Directors Amanda Edwards and Anthony Carroll.